Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?

Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?

Changing insights regarding radioiodine (I-131) administration in differentiated thyroid carcinoma (DTC) stir up discussions on the utility of pre-ablation diagnostic scintigraphy (DxWBS). Our retrospective study qualitatively and semi-quantitatively assessed posttherapy I-131 whole-body scintigraph...

Full description

Bibliographic Details
Main Authors: Elizabeth J. de Koster, Taban Sulaiman, Jaap F. Hamming, Abbey Schepers, Marieke Snel, Floris H. P. van Velden, Lioe-Fee de Geus-Oei, Dennis Vriens
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Diagnostics
Subjects:
differentiated thyroid carcinoma
radioiodine ablation
I-131
thyroid remnant
lymph node metastasis
posttherapy scintigraphy
Online Access:https://www.mdpi.com/2075-4418/11/3/553

Internet

https://www.mdpi.com/2075-4418/11/3/553

Similar Items